Form 8-K - Current report:
SEC Accession No. 0001628280-24-047461
Filing Date
2024-11-13
Accepted
2024-11-13 10:24:42
Documents
15
Period of Report
2024-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K jan-20241112.htm   iXBRL 8-K 26428
2 EX-99.1 ex991_alt5q3resultsxfinal.htm EX-99.1 22214
6 image_0.jpg GRAPHIC 116157
  Complete submission text file 0001628280-24-047461.txt   347323

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jan-20241112.xsd EX-101.SCH 1810
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jan-20241112_lab.xml EX-101.LAB 23913
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jan-20241112_pre.xml EX-101.PRE 13664
17 EXTRACTED XBRL INSTANCE DOCUMENT jan-20241112_htm.xml XML 2968
Mailing Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119
Business Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119 702-997-5968
ALT5 Sigma Corp (Filer) CIK: 0000862861 (see all company filings)

EIN.: 411454591 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19621 | Film No.: 241451787
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)